Patent details
EP1888640 Title: IMPROVED NANOBODIES AGAINST TUMOR NECROSIS FACTOR-ALPHA
Basic Information
- Publication number:
- EP1888640
- PCT Application Number:
- PCT/EP/2006/004678
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP067429621
- PCT Publication Number:
- WO/2006/122786
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- IMPROVED NANOBODIES AGAINST TUMOR NECROSIS FACTOR-ALPHA
- French Title of Invention:
- NANOCORPS AMELIORES UTILISES CONTRE LE FACTEUR-ALPHA DE NECROSE TUMORALE
- German Title of Invention:
- VERBESSERTE NANOKÖRPER GEGEN TUMORNEKROSEFAKTOR-ALPHA
- SPC Number:
Dates
- Filing date:
- 17/05/2006
- Grant date:
- 14/03/2012
- EP Publication Date:
- 14/03/2012
- PCT Publication Date:
- 23/11/2006
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 20/02/2008
- EP B1 Publication Date:
- 14/03/2012
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 17/05/2026
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 17/05/2006
- Name:
- Ablynx N.V.
- Address:
- Technologiepark 21, 9052 Ghent-Zwijnaarde, Belgium (BE)
Agent
- Name:
- ARONOVA S.A.
- From:
- 14/06/2012
- Address:
- PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
- To:
Inventor
- Name:
- BEIRNAERT Els
- Address:
- Belgium (BE)
Priority
- Priority Number:
- 682332 P
- Priority Date:
- 18/05/2005
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07K 16/18;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- 16/05/2025
- Last Annual Fee Paid Number:
- 20
- Last Annual Fee Paid Amount:
- 300 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|